Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Hydrogel with M2-derived exosomes improves wound healing by slowly releasing exosomes that help reduce inflammation and promote tissue repair.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Women may need different blood pressure guidelines than men for heart disease prevention.

Melanocyte stem cells are crucial for skin pigmentation and have potential in disease modeling and regenerative medicine.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Topical vitamin D is effective in treating vitiligo with few side effects.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Male gender and family history predict alopecia areata recurrence.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tiny particles called extracellular vesicles could help with skin healing and hair growth, but more research is needed.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Researchers developed a method to identify and analyze cyclosporin compounds and their structures effectively.